In the relentless torrent of high technology news that rushes past each day, it can be easy to miss the good stuff. For example, the debut of a cleverly designed exoskeleton that helps paraplegics walk again — and that the average person can actually afford.
Paralyzed below the waist from a car accident four years earlier, Austin Whitney did the unthinkable in 2011. He stood up from his wheelchair and walked 10 feet across the stage to get his diploma during a graduation ceremony at the University of California, Berkeley.
Not all exoskeletons need to give you superhuman strength. The exoskeleton startup company SuitX has developed an exoskeleton known as the Phoenix robotic system that was designed specifically to help people with paraplegia or other spinal cord injuries walk.
BERKELEY, CA--(Marketwired - Feb 1, 2016) -suitX, a California-based robotics company designing and manufacturing medical and industrial exoskeletons, announces the official launch of Phoenix, one of the world's lightest and most advanced medical exoskeletons for people with mobility disorders...
When a BMX bike accident broke Steve Sanchez’s back a decade ago, he was paralyzed instantly. He has needed a wheelchair ever since. But now he can have more mobility than he ever hoped.
A new exoskeleton – a robotic suit worn by a person to greatly increase their abilities – that aims to turn manufacturing and medical workers into bionic robots has been unveiled.
SuitX has qualified for the semi-final round of the UAE Robotics and Ai Award for Good International Competition for the development of an affordable exoskeleton targeting children with neurological disorders. The competition finals, as well as a live demonstration will take place in Dubai...
On Wednesday, November 18th, SuitX (US Bionics) received the third place award for MAX Industrial System at the NOVA Innovation Competition hosted by Saint Gobain.
SuitX (U.S.Bionics) has received a SBIR Phase II grant for almost $750,000 from the National Science Foundation. U.S. Bionics was awarded this grant after the successful completion of research and demonstrating the commercialization potential of its technology during the Phase I grant period.